Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    FMR1
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Terminated Analysis of Oculo-motor Deficiencies Associated With FMR1 Gene Expression (Genetic Abnormality Predisposing to a Neurodegenerative Disease)
Condition: Pre-mutation on FMR1 Gene
Interventions: Other: examination of ocular movements;   Other: MATTIS test;   Other: UPDRS test;   Other: CRST test
2 Terminated The Natural History of Reproductive and Overall Health in Girls and Women With a Pre-Mutation in the FMR1 Gene; Creation of a Patient Registry
Conditions: Fragile X Syndrome;   FMR1 Premutation;   Primary Ovairan Insufficiency;   Premature Ovarian Failure;   Premature Menopause
Intervention:
3 Not yet recruiting Brain Network Activation and Gait and Posture in FXTAS
Conditions: Fragile X Associated Tremor-ataxia Syndrome;   FXTAS
Intervention:
4 Completed Safety and Efficacy Study of Antioxidants for the Treatment of the Fragile X Syndrome
Condition: Fragile X Syndrome
Interventions: Dietary Supplement: Ascorbic Acid (Vitamin C) and Alpha-tocopherol (Vitamin E);   Dietary Supplement: Placebo
5 Completed Study of the Involvement of 15q11 - q13 Chromosome Region and CYFIP1 Gene in Autism. Attempt a Genotype-phenotype Correlation
Condition: Autistic Disorder
Intervention: Genetic: Genetic test
6 Unknown  Premature Ovarian Failure (Genetic and Physiopathologic Analysis)
Condition: Premature Ovarian Failure
Intervention:
7 Recruiting Combined Treatment of Minocycline and Lovastatin to Treat Individuals With Fragile X Syndrome
Condition: Fragile X Syndrome
Interventions: Drug: Minocycline, then Minocycline/Lovastatin;   Drug: Lovastatin, then Minocycline/Lovastatin
8 Completed Examining Physiology and Brain Function in People With the Fragile X Premutation
Condition: Fragile X Premutation
Intervention:
9 Completed Examining Social, Emotional, and Cognitive Functioning in People With Fragile X and Down Syndromes
Conditions: Anxiety Disorders;   Child Developmental Disorders, Pervasive
Intervention:

Study has passed its completion date and status has not been verified in more than two years.